The «El Álamo» project (1990-1997): Two consecutive hospital-based studies of breast cancer outcomes in Spain

Clinical and Translational Oncology

Volumn 8, Issue 7, 2006, Pages 508-518

  Martín, Miguel ^a   Mahillo, Esther ^b   Llombart Cussac, Antonio ^c   Lluch, Ana ^d   Munarriz, Blanca ^e   Pastor, Miguel ^e   Alba, Emilio ^f   Ruiz, Amparo ^c   Antón, Antonio ^g   Bermejo, Begoña ^d  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Grupo Español de Investigación en Cáncer de Mama   (Spain)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Age distribution; Breast cancer; Chemotherapy; Hormonal therapy; Spain; Stage distribution; Survival

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; DOCETAXEL; EXEMESTANE; FORMESTANE; GONADORELIN DERIVATIVE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA COLLECTION METHOD; FEMALE; HOSPITAL CARE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SPAIN; SURVIVAL RATE; SURVIVAL TIME; AGED; BREAST TUMOR; MIDDLE AGED; REGISTER; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 33748875501     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0051-7     Document Type: Article

References (20)

1. Althius MD, Dozier JD, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005;54(2):405-12.
2. López-Abente G, Pollán M, Aragonés N, Pérez-Gómez B. Informe sobre la salud de los españoles. http://195.146.50.130/htdocs/cancer/ memoria-2003-cancer.pdf
3. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1997, version 4.0 IARC CancerBase No. 4 Lyon IARCPress, 1999.
4. WHO-IARG, Worldwide cancer mortality statistics, International Agency for Research on Cancer 2002 www-depdb.iarc./fr/who/mortality.asp
5. INE http://www.ine.es.
6. www.geicam.org
7. Goldhirsch A, Glick JH, Gelber RD, Senn HJ, Meeting Highlights. International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst. 1998;90:1601-8.
8. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
9. Martín M, Llombart-Cussac A, Lluch A, et al. Proyecto El Álamo: Un estudio epidemiológico del grupo GEICAM sobre ei cáncer de mama es España (1990-1993). Medécina Clínica, 2004;122:12-7.
10. Rosen PP. Invasive mammary carcinoma. In: Harris JR, Lippman ME, Morrow M and Hellman, editors. Diseases of the Breast. Lippincott-Raven: Philadelphia; 1996. p. 393-444.
11. Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: What do we know? J Clin Oncol. 2002;20:4381-93.
12. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD. Frequency of oestrogen and progesterone receptor positivey by immunohistochemical analysis in 7016 breast carcinomas: Correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol. 2000;55:688-96.
13. Osteeu R, Steele G, Merck HR, Winchester DP, Regional differences in surgical management of breast cancer. CA Cancer J Clin. 1992;42:59-43.
14. Lazovich D, White E, Thomas DB, Moe RE, Taplin S. Change in the use of Breast-Conerving Surgery in Western Washington After the 1990 IH Consensus Development Conference. Arch Surg. 1997;132:418-23.
15. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312(11):665-75.
16. NIH Consensus Conference. Treatment of early breast cancer. JAMA. 1991;265:391-5.
17. Sant M, Aareleid T, Berrino F, et al. for the EUROCARE Working Group. EURO-CARE-3: Survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol. 2005;14Suppl 5:v61-118.
18. Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metastases: Trends in survival during a 14-year period. J Clin Oncol. 2004;22(16):3302-8.
19. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer. 2004;100 (1):44-52.
20. Colomer R, Viñas G, Beltrán M, et al. Validation of the 2001 St Gallen Risk Categories for Node-Negative Breast Cancer Using a Database From the Spanish Breast Cancer Research Group (GEICAM). J Clin Oncol. 2004. p. 961-2.